Orthofix Medical Inc. (OFIX)
13.46
0.32 (2.44%)
At close: Apr 23, 2025, 3:59 PM
13.42
-0.33%
After-hours: Apr 23, 2025, 05:30 PM EDT
Orthofix Medical Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Global Orthopedics Revenue | 30.5M | 30.59M | 27.32M | 30.63M | 29.65M | 29.04M | 26M | 28.68M | 27.81M | 27.29M |
| Global Orthopedics Revenue Growth | -0.27% | +11.98% | -10.82% | +3.29% | +2.11% | +11.70% | -9.35% | +3.12% | +1.91% | n/a |
| Global Spine Revenue | 166.1M | 168.03M | 161.29M | 169.78M | 154.35M | 157.98M | 149.21M | 93.55M | 86.19M | 90.78M |
| Global Spine Revenue Growth | -1.15% | +4.18% | -5.00% | +10.00% | -2.29% | +5.88% | +59.49% | +8.55% | -5.06% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brazil Revenue | 6.45M | 5.67M | 5.11M | 2.35M | 7.68M | 7.12M | 10.36M | 11.33M | 50.44M | 56.99M | 51.13M | 56.42M |
| Brazil Revenue Growth | +13.83% | +10.96% | +117.64% | -69.46% | +7.94% | -31.25% | -8.63% | -77.53% | -11.49% | +11.45% | -9.37% | n/a |
| Delaware Revenue | 11.47M | 11.57M | 13.72M | 11.94M | 12.69M | 11.61M | 17.06M | 16.66M | n/a | n/a | n/a | n/a |
| Delaware Revenue Growth | -0.88% | -15.65% | +14.87% | -5.90% | +9.32% | -31.97% | +2.37% | n/a | n/a | n/a | n/a | n/a |
| France Revenue | 11.1M | 10.38M | 10.47M | 18.73M | 19.56M | 19.33M | 52.54M | 54.55M | n/a | n/a | n/a | n/a |
| France Revenue Growth | +6.93% | -0.94% | -44.08% | -4.23% | +1.18% | -63.21% | -3.70% | n/a | n/a | n/a | n/a | n/a |
| Italy Revenue | 20.06M | 19.1M | 20.19M | 39.12M | 47.99M | 50.9M | n/a | n/a | n/a | n/a | n/a | n/a |
| Italy Revenue Growth | +5.04% | -5.39% | -48.39% | -18.50% | -5.71% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Countries Revenue | 65.83M | 44.99M | 42.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Countries Revenue Growth | +46.32% | +5.86% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 130.14M | 134.12M | 131.69M | 132.28M | 122.08M | 133.43M | 142.6M | 84.79M | 74.78M | 75.73M | 73.47M | 75.36M | 72.41M | 75.67M | 67.23M | 72.21M | 69.47M | 58.53M | 72.18M | 80.42M | 75.89M | 78.8M | 74.17M | 73.88M | 72.6M | 73.8M | 69.75M | 71.35M | 65.56M | 70.88M | 66.81M | 69.77M | 60.3M | 63.99M | 61.53M | 68.45M | 65.48M | 65.45M | 65.45M |
| Selling, General, and Administrative Revenue Growth | -2.97% | +1.84% | -0.45% | +8.36% | -8.50% | -6.43% | +68.17% | +13.39% | -1.26% | +3.09% | -2.51% | +4.08% | -4.31% | +12.56% | -6.90% | +3.95% | +18.69% | -18.91% | -10.25% | +5.97% | -3.69% | +6.25% | +0.39% | +1.76% | -1.62% | +5.80% | -2.25% | +8.84% | -7.50% | +6.09% | -4.23% | +15.71% | -5.77% | +3.99% | -10.11% | +4.55% | +0.04% | 0.00% | n/a |
| Research and Development Revenue | 17.29M | 18.05M | 19.49M | 18.94M | 18.56M | 19.42M | 23.31M | 13.15M | 11.94M | 12.76M | 11.21M | 13.24M | 12.36M | 13.12M | 10.9M | 10.37M | 9.96M | 8.77M | 9.96M | 8.45M | 7.98M | 8.98M | 9.23M | 8.79M | 9.6M | 7.89M | 6.94M | 8.45M | 6.93M | 6.89M | 7.42M | 7.51M | 6.86M | 6.79M | 7.64M | 7.57M | 6.52M | 6.45M | 5.84M |
| Research and Development Revenue Growth | -4.18% | -7.40% | +2.91% | +2.06% | -4.45% | -16.66% | +77.21% | +10.12% | -6.39% | +13.79% | -15.34% | +7.14% | -5.80% | +20.41% | +5.13% | +4.05% | +13.66% | -12.03% | +17.97% | +5.81% | -11.11% | -2.70% | +4.97% | -8.40% | +21.63% | +13.75% | -17.94% | +21.90% | +0.70% | -7.23% | -1.13% | +9.49% | +0.97% | -11.05% | +0.87% | +16.05% | +1.12% | +10.37% | n/a |
| Sales and Marketing Revenue | 96.58M | 100.22M | 100.04M | 97.75M | 94.95M | 99.25M | 93.79M | 59.32M | 55.46M | 59.89M | 54.14M | 57.1M | 56.1M | 57.34M | 50.78M | 53.72M | 52.93M | 43.48M | 54.31M | 58.31M | 54.8M | 56.86M | 53.69M | 53.83M | 49.9M | 51.53M | 50.27M | 51.87M | 47.49M | 50.47M | 48.53M | 48.7M | 41.72M | 46.04M | 44.82M | 44.72M | 46.13M | 42.95M | 44.28M |
| Sales and Marketing Revenue Growth | -3.64% | +0.18% | +2.35% | +2.95% | -4.33% | +5.82% | +58.10% | +6.97% | -7.39% | +10.62% | -5.19% | +1.78% | -2.16% | +12.90% | -5.46% | +1.49% | +21.73% | -19.95% | -6.86% | +6.40% | -3.62% | +5.90% | -0.26% | +7.88% | -3.17% | +2.51% | -3.10% | +9.22% | -5.90% | +4.00% | -0.36% | +16.75% | -9.38% | +2.72% | +0.21% | -3.05% | +7.41% | -3.02% | n/a |